DudeDiligence.

Rapport Therapeutics, Inc

RAPPNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

Shares on issue

48.1M

From 36.6M in June 2024

a raise that quarter, at its price

Newest

No limit

S-3ASR of 2026-03-10. An automatic shelf: the form sets no dollar limit. 1 prospectus supplement filed under it since.

$110.0M

Leerink Partners, agreement of 2026-01-07. No at-the-market sales on file.

Warrants

No warrant count on file.

Cash

13.1 quarters

$395.0M cash on hand.

Raised
DateWhatSharesPriceGrossFiling
2026-10-30Private placement1,428,571not available$30.0M8-K ↗
2026-10-28Public offering incl. 1.19M pre-funded9,523,810$21.00$200.0M424B5 ↗
2025-09-09Public offering9,615,385$26.00$250.0M424B5 ↗
2024-06-06Public offering8,000,000$17.00not available424B4 ↗

Also on file: $150.0M convertible notes, 2026-10-28 424B5 ↗ · $150.0M convertible notes, 2026-10-28 8-K ↗